Outside of covid-19 diagnostics: Nine out of 16 APAC IVD markets have recovered to pre-pandemic levels

Article tags Centralised Diagnostics (CEDx)In-vitro diagnosticsMolecular Diagnostics (MDx)Next Generation Sequencing (NGS)Tissue Diagnostics (TDx)AsiaCentralised Diagnostics (CEDx)Covid-19 testingInfectious Diseases Testing MonitorIVD GatewayMolecular Diagnostics (MDx)

Asia-Pacific (APAC) IVD markets have grown and exceeded their pre-pandemic size in 2019. This growth is largely due to covid-19 testing. 

When controlling for covid-19 testing, we find that only nine out of 16 markets—including China, South Korea and several southeast Asian countries, have recovered to pre-pandemic levels.

Rapid MDx expansion during covid-19 not enough to cover lack of recovery in CEDx

The molecular diagnostics (MDx) segment has expanded faster than centralised diagnostics (CEDx) across APAC since the pandemic. In some countries such as Indonesia, strong MDx growth has helped make up for the relative stagnation of CEDx and contributes to overall market recovery and growth. However in other markets, the MDx growth is not enough for the overall market to recover to pre-pandemic levels.

Despite all markets experiencing growth in the MDx segment, it is not enough for the overall market to recover in some countries. The lack of recovery in the CEDx market segment covering clinical chemistry (CC) and immunoassays (IA) is the key reason why non-covid-19 diagnostics markets such as the Philippines and Vietnam have yet to recover. In these countries, CC and IA segments are still not at 2019 levels.

For more on the recovery and growth trends in key IVD market segments in APAC, download the white paper on Inside Asia-Pacific’s IVD market: Post-pandemic recovery trends and the future outlook

Thu, 28th Jul 2022 Article tags Centralised Diagnostics (CEDx)In-vitro diagnosticsMolecular Diagnostics (MDx)Next Generation Sequencing (NGS)Tissue Diagnostics (TDx)AsiaCentralised Diagnostics (CEDx)Covid-19 testingInfectious Diseases Testing MonitorIVD GatewayMolecular Diagnostics (MDx)